Sarcopenia: Revised European consensus on definition and diagnosis
Alfonso J. Cruz-Jentoft,Gulistan Bahat,Jürgen M. Bauer,Yves Boirie,Olivier Bruyère,Tommy Cederholm,Cyrus Cooper,Francesco Landi,Yves Rolland,Avan Aihie Sayer,Stéphane M. Schneider,Cornel C. Sieber,Eva Topinkova,Maurits Vandewoude,Marjolein Visser,Mauro Zamboni +15 more
TLDR
An emphasis is placed on low muscle strength as a key characteristic of sarcopenia, uses detection of low muscle quantity and quality to confirm the sarc Openia diagnosis, and provides clear cut-off points for measurements of variables that identify and characterise sarc openia.Abstract:
Background in 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) published a sarcopenia definition that aimed to foster advances in identifying and caring for people with sarcopenia. In early 2018, the Working Group met again (EWGSOP2) to update the original definition in order to reflect scientific and clinical evidence that has built over the last decade. This paper presents our updated findings. Objectives to increase consistency of research design, clinical diagnoses and ultimately, care for people with sarcopenia. Recommendations sarcopenia is a muscle disease (muscle failure) rooted in adverse muscle changes that accrue across a lifetime; sarcopenia is common among adults of older age but can also occur earlier in life. In this updated consensus paper on sarcopenia, EWGSOP2: (1) focuses on low muscle strength as a key characteristic of sarcopenia, uses detection of low muscle quantity and quality to confirm the sarcopenia diagnosis, and identifies poor physical performance as indicative of severe sarcopenia; (2) updates the clinical algorithm that can be used for sarcopenia case-finding, diagnosis and confirmation, and severity determination and (3) provides clear cut-off points for measurements of variables that identify and characterise sarcopenia. Conclusions EWGSOP2's updated recommendations aim to increase awareness of sarcopenia and its risk. With these new recommendations, EWGSOP2 calls for healthcare professionals who treat patients at risk for sarcopenia to take actions that will promote early detection and treatment. We also encourage more research in the field of sarcopenia in order to prevent or delay adverse health outcomes that incur a heavy burden for patients and healthcare systems.read more
Citations
More filters
Journal ArticleDOI
Long Term Follow-Up of Sarcopenia and Malnutrition after Hospitalization for COVID-19 in Conventional or Intensive Care Units
D Levy,Margherita Giannini,Walid Oulehri,Marianne Riou,C. Marcot,Mégane Pizzimenti,L. Debrut,Anne Charloux,Bernard Geny,Alain Meyer +9 more
TL;DR: Sarcopenia and malnutrition are frequently observed in patients hospitalized for COVID-19, even 3 months after infection occurrence, but can largely be reversed at 6 months after discharge, particularly during long stays in an ICU.
Journal ArticleDOI
Is muscle failure a better term than sarcopenia
TL;DR: An ongoing discussion within the interest field of sarcopenia is what assessments should be included, and the lack of agreement is probably due to the diverse backgrounds of the researchers involved, ranging from epidemiology to muscle physiology and cell biology.
Journal ArticleDOI
Mapping ongoing nutrition intervention trials in muscle, sarcopenia, and cachexia: a scoping review of future research
Camila E. Orsso,Montserrat Montes-Ibarra,Merran Findlay,Barbara S. van der Meij,Marian A. E. de van der Schueren,Francesco Landi,Alessandro Laio,Carla M. Prado +7 more
TL;DR: Although many trials have similar type of interventions, methodological heterogeneity may challenge study comparisons, and future meta‐analyses aiming to provide evidence‐based recommendations may benefit from guidelines for the assessment of therapeutic effects of nutrition interventions.
Journal ArticleDOI
Prediction Equations of the Multifrequency Standing and Supine Bioimpedance for Appendicular Skeletal Muscle Mass in Korean Older People.
Kwon Chan Jeon,So-Young Kim,Fang Lin Jiang,Sochung Chung,Jatin P. Ambegaonkar,Jae-Hyeon Park,Young-Joo Kim,Chul-Hyun Kim,Chul-Hyun Kim +8 more
TL;DR: The overall agreement between the measured and predicted ASM index as sarcopenia diagnosis is assessed and the new multifrequency bioelectrical impedance analysis (MF-BIA) prediction equations are useful for epidemiological and field settings as well as a clinical diagnosis of sarc Openia.
Journal ArticleDOI
Skeletal Muscle Quality: A Biomarker for Assessing Physical Performance Capabilities in Young Populations.
TL;DR: In this article, a review of the evidence base to establish this metric as a practical and important biomarker for functional capacity and performance in healthy, young populations is presented, and interventions that enhance MQ, such as high-intensity stretch shortening contraction resistance exercise training, are highlighted.
References
More filters
Journal ArticleDOI
Frailty in Older Adults Evidence for a Phenotype
Linda P. Fried,Catherine M. Tangen,Jeremy D. Walston,Anne B. Newman,Calvin H. Hirsch,John S. Gottdiener,Teresa E. Seeman,Russell P. Tracy,Willem J. Kop,B Gregory Burke,Mary Ann McBurnie +10 more
TL;DR: This study provides a potential standardized definition for frailty in community-dwelling older adults and offers concurrent and predictive validity for the definition, and finds that there is an intermediate stage identifying those at high risk of frailty.
Journal ArticleDOI
The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons
TL;DR: This study evaluated a modified, timed version of the “Get‐Up and Go” Test (Mathias et al, 1986) in 60 patients referred to a Geriatric Day Hospital and suggested that the timed “Up & Go’ test is a reliable and valid test for quantifying functional mobility that may also be useful in following clinical change over time.
Journal Article
Cardiovascular Health Study Collaborative Research Group : Frailty in older adults : evidence for a phenotype
Journal ArticleDOI
Sarcopenia: European consensus on definition and diagnosis Report of the European Working Group on Sarcopenia in Older People
Alfonso J. Cruz-Jentoft,Jean-Pierre Baeyens,Jürgen M. Bauer,Yves Boirie,Tommy Cederholm,Francesco Landi,Finbarr C. Martin,Jean-Pierre Michel,Yves Rolland,Stéphane M. Schneider,Eva Topinkova,Maurits Vandewoude,Mauro Zamboni +12 more
TL;DR: The European Working Group on Sarcopenia in Older People (EWGSOP) developed a practical clinical definition and consensus diagnostic criteria for age-related sarcopenia as discussed by the authors.
Journal ArticleDOI
Frailty in elderly people
TL;DR: Developing more efficient methods to detect frailty and measure its severity in routine clinical practice would greatly inform the appropriate selection of elderly people for invasive procedures or drug treatments and would be the basis for a shift in the care of frail elderly people towards more appropriate goal-directed care.
Related Papers (5)
Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia.
Liang Kung Chen,Li Kuo Liu,Jean Woo,Prasert Assantachai,Tung Wai Auyeung,Kamaruzzaman Shahrul Bahyah,Ming Yueh Chou,Liang Yu Chen,Pi Shan Hsu,Orapitchaya Krairit,Jenny S.W. Lee,Wei Ju Lee,Yunhwan Lee,Chih Kuang Liang,Panita Limpawattana,Chu Sheng Lin,Li Ning Peng,Shosuke Satake,Takao Suzuki,Chang Won Won,Chih Hsing Wu,Si Nan Wu,Teimei Zhang,Ping Zeng,Masahiro Akishita,Hidenori Arai +25 more
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
Liang Kung Chen,Jean Woo,Prasert Assantachai,Tung Wai Auyeung,Ming Yueh Chou,Katsuya Iijima,Hak Chul Jang,Lin Kang,Miji Kim,Sunyoung Kim,Taro Kojima,Masafumi Kuzuya,Jenny S.W. Lee,Sang Yoon Lee,Wei Ju Lee,Yunhwan Lee,Chih Kuang Liang,Jae Young Lim,Wee Shiong Lim,Li Ning Peng,Ken Sugimoto,Tomoki Tanaka,Chang Won Won,Minoru Yamada,Teimei Zhang,Masahiro Akishita,Hidenori Arai +26 more
The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia.
Roger A. Fielding,Bruno Vellas,William J. Evans,Shalender Bhasin,John E. Morley,Anne B. Newman,Gabor Abellan van Kan,Sandrine Andrieu,Juergen M. Bauer,Denis Breuille,Tommy Cederholm,Julie Chandler,Capucine De Meynard,Lorenzo M. Donini,Tamara B. Harris,Aimo Kannt,Florence Keime Guibert,Graziano Onder,Dimitris Papanicolaou,Yves Rolland,Daniel Rooks,Cornel C. Sieber,Elisabeth Souhami,Sjors Verlaan,Mauro Zamboni +24 more